AIM
GSK icon

Allen Investment Management’s GSK GSK Stock Holding History

Allen Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-18,544
Closed -$965K – 207
2015
Q2 		$965K Sell
18,544
-2,333
-11% -$131K 0.09% 99
2015
Q1 		$1.2M Sell
20,877
-12,978
-38% -$744K 0.09% 92
2014
Q4 		$1.81M Sell
33,855
-138,332
-80% -$7.74M 0.14% 78
2014
Q3 		$9.89M Buy
172,187
+22,972
+15% +$1.41M 0.82% 42
2014
Q2 		$9.97M Hold
149,215
– – 1.04% 39
2014
Q1 		$9.97M Buy
149,215
+10,378
+7% +$702K 1.55% 23
2013
Q4 		$9.27M Buy
+138,837
New +$9M 1.96% 24

Other funds holding GSK

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Allen Investment Management's GSK Position: Q3 2015 in Review

Allen Investment Management sold out of GSK (GSK) in Q3 2015, closing a stake of 18,544 shares — an estimated $965K sold.

Allen Investment Management first reported a position in GSK in Q4 2013 and held it in 7 quarters. The position peaked at $9.97M in Q2 2014. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • Allen Investment Management reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
  • Allen Investment Management sold 18,544 GSK shares in Q3 2015, an estimated $965K.
  • Allen Investment Management first reported a position in GSK in Q4 2013 and held it in 7 quarters.
  • Allen Investment Management's GSK position peaked at $9.97M in Q2 2014.
  • 706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Allen Investment Management's 13F filing for Q3 2015, filed 16 Nov 2015.